BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 23831857)

  • 1. Mathematical modeling in cancer drug discovery.
    Wang Z; Deisboeck TS
    Drug Discov Today; 2014 Feb; 19(2):145-50. PubMed ID: 23831857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current mathematical models for cancer drug discovery.
    Carrara L; Lavezzi SM; Borella E; De Nicolao G; Magni P; Poggesi I
    Expert Opin Drug Discov; 2017 Aug; 12(8):785-799. PubMed ID: 28595492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical modeling for novel cancer drug discovery and development.
    Zhang P; Brusic V
    Expert Opin Drug Discov; 2014 Oct; 9(10):1133-50. PubMed ID: 25062617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational modeling in melanoma for novel drug discovery.
    Pennisi M; Russo G; Di Salvatore V; Candido S; Libra M; Pappalardo F
    Expert Opin Drug Discov; 2016 Jun; 11(6):609-21. PubMed ID: 27046143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mathematical modeling of efficacy and safety for anticancer drugs clinical development.
    Lavezzi SM; Borella E; Carrara L; De Nicolao G; Magni P; Poggesi I
    Expert Opin Drug Discov; 2018 Jan; 13(1):5-21. PubMed ID: 28972401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing oncology therapeutics through quantitative translational and clinical pharmacology: challenges and opportunities.
    Venkatakrishnan K; Friberg LE; Ouellet D; Mettetal JT; Stein A; Trocóniz IF; Bruno R; Mehrotra N; Gobburu J; Mould DR
    Clin Pharmacol Ther; 2015 Jan; 97(1):37-54. PubMed ID: 25670382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted approaches to childhood cancer: progress in drug discovery and development.
    Hirsch S; Marshall LV; Carceller Lechon F; Pearson AD; Moreno L
    Expert Opin Drug Discov; 2015 May; 10(5):483-95. PubMed ID: 25840490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel drugs for promising targets.
    Martell RE; Brooks DG; Wang Y; Wilcoxen K
    Clin Ther; 2013 Sep; 35(9):1271-81. PubMed ID: 24054704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancing cancer drug discovery towards more agile development of targeted combination therapies.
    Carragher NO; Unciti-Broceta A; Cameron DA
    Future Med Chem; 2012 Jan; 4(1):87-105. PubMed ID: 22168166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Big data' approaches for novel anti-cancer drug discovery.
    Benstead-Hume G; Wooller SK; Pearl FMG
    Expert Opin Drug Discov; 2017 Jun; 12(6):599-609. PubMed ID: 28462602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-engineered 3D tumor angiogenesis models: potential technologies for anti-cancer drug discovery.
    Chwalek K; Bray LJ; Werner C
    Adv Drug Deliv Rev; 2014 Dec; 79-80():30-9. PubMed ID: 24819220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The path to oncology drug target validation: an industry perspective.
    Cortés-Cros M; Schmelzle T; Stucke VM; Hofmann F
    Methods Mol Biol; 2013; 986():3-13. PubMed ID: 23436402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serendipity in Cancer Drug Discovery: Rational or Coincidence?
    Prasad S; Gupta SC; Aggarwal BB
    Trends Pharmacol Sci; 2016 Jun; 37(6):435-450. PubMed ID: 27083322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-targeted hybrids based on HDAC inhibitors for anti-cancer drug discovery.
    Seo SY
    Arch Pharm Res; 2012 Feb; 35(2):197-200. PubMed ID: 22370774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse tumour models to guide drug development and identify resistance mechanisms.
    Das Thakur M; Pryer NK; Singh M
    J Pathol; 2014 Jan; 232(2):103-11. PubMed ID: 24122209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network pharmacology for cancer drug discovery: are we there yet?
    Azmi AS
    Future Med Chem; 2012 May; 4(8):939-41. PubMed ID: 22650234
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of Antineoplastic Targets with Systems Approaches, Using Resveratrol as an In-Depth Case Study.
    Singh N; Freiesleben S; Wolkenhauer O; Shukla Y; Gupta SK
    Curr Pharm Des; 2017; 23(32):4773-4793. PubMed ID: 28699531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer drug discovery: recent innovative approaches to tumor modeling.
    Lovitt CJ; Shelper TB; Avery VM
    Expert Opin Drug Discov; 2016 Sep; 11(9):885-94. PubMed ID: 27454169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A snapshot of challenges and solutions in cancer drug development and therapy.
    Phelps MA; Sparreboom A
    Clin Pharmacol Ther; 2014 Apr; 95(4):341-6. PubMed ID: 24646480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.